Q2 2025 Holdings
Filed 2025-08-14 | 20 holdings | $198.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-02-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $50.0M | 9,771,485 | 25.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $29.2M | 792,977 | 14.7% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $20.5M | 2,211,341 | 10.3% |
| Merus N V | COM | N5749R100 | $19.2M | 365,000 | 9.7% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $18.9M | 432,010 | 9.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $12.5M | 899,500 | 6.3% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $8.2M | 825,000 | 4.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $7.9M | 575,000 | 4.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $7.9M | 1,225,000 | 4.0% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $7.3M | 453,686 | 3.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.3M | 60,000 | 1.7% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $3.2M | 125,000 | 1.6% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $2.8M | 750,000 | 1.4% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $2.7M | 55,000 | 1.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $2.0M | 175,000 | 1.0% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $1.5M | 70,700 | 0.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.1M | 93,400 | 0.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $427.5K | 25,000 | 0.2% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $72.0K | 266,666 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $1.2K | 66,666 | 0.0% |